RI
LENZ

Rinkey Investments’s LENZ Therapeutics LENZ Stock Holding History

Rinkey Investments’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$139K Hold
15,186
– – 0.04% 124
2025
Q4 		$243K Hold
15,186
– – 0.06% 114
2025
Q3 		$707K Hold
15,186
– – 0.19% 60
2025
Q2 		$445K Hold
15,186
– – 0.13% 65
2025
Q1 		$390K Hold
15,186
– – 0.12% 63
2024
Q4 		$438K Hold
15,186
– – 0.14% 60
2024
Q3 		$361K Buy
+15,186
New +$337K 0.12% 62

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Rinkey Investments's LENZ Position: Q1 2026 in Review

Rinkey Investments held its LENZ Therapeutics (LENZ) position steady in Q1 2026 at 15,186 shares worth $139K. The position accounts for 0.04% of the portfolio, ranked #124.

Rinkey Investments first reported a position in LENZ in Q3 2024 and has held it in 7 quarters since. The position peaked at $707K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Rinkey Investments held 15,186 shares of LENZ Therapeutics worth $139K as of Q1 2026.
  • Rinkey Investments left its LENZ Therapeutics share count unchanged in Q1 2026.
  • LENZ Therapeutics made up 0.04% of Rinkey Investments's portfolio in Q1 2026, its #124 holding.
  • Rinkey Investments first reported a position in LENZ Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Rinkey Investments's LENZ Therapeutics position peaked at $707K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Rinkey Investments's 13F filing for Q1 2026, filed 11 May 2026.